31hP
31hP is an asymmetric A3 lipid. 31hP can facilitate in vivo luciferase expression. 31hP can be rapidly degraded in the presence of esterase owing to two biocleavable ester bonds. 31hP can be used in the synthesis of lipid nanoparticles (LNPs).
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C49H86N2O4
- Peso molecular:767.22
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Chemical Information
-
Peso molecular 767.22
-
Fòrmula C49H86N2O4
-
SMILES
CCCCCCCCC(OC(C(C=C1)=CC=C1C(N(CCN(CC)CC)C)C#CCCCC(OC(CCCCCCCC)CCCCCCCC)=O)=O)CC
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (264 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Lipid Nanoparticles: Key Nucleic Acid Delivery Vectors
Lipid nanoparticles (LNPs) are the most clinically advanced non-viral delivery systems for nucleic acid therapeutics and enable the in vivo delivery of mRNA, siRNA, and other genetic cargos.
2026-06-18
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)